{
  "simulation_id": "sim_20250503_162304",
  "config": {
    "use_team_leadership": false,
    "use_closed_loop_comm": false,
    "use_mutual_monitoring": false,
    "use_shared_mental_model": false,
    "use_team_orientation": false,
    "use_mutual_trust": true,
    "mutual_trust_factor": 0.9,
    "use_recruitment": true,
    "recruitment_method": "advanced",
    "recruitment_pool": "general",
    "random_leader": false,
    "task": "Autoimmune Encephalitis Diagnosis"
  },
  "exchanges": [
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "1_Initial Assessment Team_Neurologist",
      "message": "**Correct Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating the insights from all team members and considering the clinical presentation, imaging findings, and diagnostic data, the most likely autoantibody associated with this case is **anti-LGI1 antibodies**. \n\n- **Clinical Presentation:** Subacute memory deficits, confusion, and behavioral changes are hallmark features of limbic encephalitis, which is strongly associated with anti-LGI1 antibodies.\n- **MRI Findings:** Bilateral medial temporal lobe hyperintensities are classic for anti-LGI1 encephalitis.\n- **CSF Findings:** Mild lymphocytic pleocytosis is consistent with the inflammatory process seen in anti-LGI1 encephalitis.\n- **EEG Findings:** Focal slowing in the temporal regions aligns with limbic system dysfunction, further supporting the diagnosis.\n\nWhile other options (e.g., anti-NMDA receptor, anti-GABA-B receptor, and anti-AMPA receptor antibodies) may present with overlapping features, they are less consistent with the specific combination of clinical, radiological, and laboratory findings in this case. Anti-LGI1 encephalitis is the most fitting diagnosis, particularly in a 32-year-old patient without evidence of malignancy or other atypical features. \n\n**Final Answer: B. Anti-LGI1 antibodies**"
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "1_Initial Assessment Team_Infectious Disease Specialist",
      "message": "**Final Answer: B**\n\n**Rationale:**\nAfter integrating the analyses from all team members and considering the clinical presentation, diagnostic findings, and autoimmune encephalitis subtypes:\n\n1. **Clinical Presentation:** The patient\u2019s subacute onset of memory deficits, confusion, and behavioral changes over 3 weeks strongly suggests limbic encephalitis.\n2. **MRI Findings:** Bilateral medial temporal lobe hyperintensities are hallmark findings of limbic encephalitis, particularly anti-LGI1 encephalitis.\n3. **CSF Findings:** Mild lymphocytic pleocytosis supports an inflammatory or autoimmune process.\n4. **EEG Findings:** Focal slowing in the temporal regions aligns with dysfunction in the limbic system.\n5. **Differentiation of Options:** Anti-LGI1 antibodies are the most common cause of autoimmune limbic encephalitis in middle-aged adults, and the imaging, CSF, and EEG findings strongly align with this diagnosis. Other options, such as anti-NMDA receptor, anti-GABA-B receptor, and anti-AMPA receptor antibodies, are less likely due to differences in clinical features, imaging findings, and associations with malignancy or specific syndromes.\n\n**Consensus:** All team members agree that **anti-LGI1 antibodies** are the most likely cause of this patient\u2019s presentation. This diagnosis is supported by the clinical, radiological, and laboratory findings.\n\n**Correct Answer: B. Anti-LGI1 antibodies**"
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "1_Initial Assessment Team_Radiologist",
      "message": "**B. Anti-LGI1 antibodies**\n\n**Rationale**: The patient\u2019s clinical presentation, including subacute onset of memory deficits, confusion, and behavioral changes, along with MRI findings of bilateral medial temporal lobe hyperintensities, CSF analysis showing mild lymphocytic pleocytosis, and EEG findings of focal slowing in the temporal regions, is highly characteristic of **limbic encephalitis**. Among the given options, **anti-LGI1 antibodies** are the most strongly associated with this syndrome, particularly in middle-aged adults. This diagnosis is supported by radiological, clinical, and laboratory findings, and no significant evidence suggests alternative autoantibodies."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "2_Diagnostic Evidence Team_Rheumatologist",
      "message": "**B. Anti-LGI1 antibodies**\n\n### Rationale:\nAfter integrating the analyses from all team members and considering the clinical presentation, imaging findings, and diagnostic data, the most consistent diagnosis is **anti-LGI1 antibody-associated limbic encephalitis**. \n\n1. **Clinical Presentation**: The subacute onset of memory deficits, confusion, and behavioral changes is highly characteristic of limbic encephalitis.\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are a hallmark of anti-LGI1 encephalitis.\n3. **CSF Findings**: Mild lymphocytic pleocytosis aligns with a diagnosis of autoimmune encephalitis.\n4. **EEG Findings**: Focal slowing in the temporal regions is a common finding in anti-LGI1 encephalitis.\n5. **Differentiation**:\n   - Anti-NMDA receptor encephalitis typically presents with more prominent psychiatric symptoms and movement disorders, with less specific MRI findings.\n   - Anti-GABA-B receptor and anti-AMPA receptor encephalitis are often associated with malignancies, which are not described in this case.\n   - The patient's age and presentation are most consistent with anti-LGI1 encephalitis, which is a classic cause of non-paraneoplastic limbic encephalitis.\n\nThus, **anti-LGI1 antibodies** are the most likely autoantibody associated with this clinical presentation."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "2_Diagnostic Evidence Team_Immunologist",
      "message": "**B. Anti-LGI1 antibodies**\n\n### Rationale:\nThe patient's clinical presentation, imaging findings, and diagnostic data strongly align with **anti-LGI1 antibody-associated encephalitis**, a form of autoimmune limbic encephalitis. Here is the integrated reasoning:\n\n1. **Clinical Presentation**: Subacute onset of memory deficits, confusion, and behavioral changes is highly characteristic of limbic encephalitis, often caused by anti-LGI1 antibodies.\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are a hallmark of anti-LGI1 encephalitis.\n3. **CSF Findings**: Mild lymphocytic pleocytosis is common in anti-LGI1 encephalitis and supports an autoimmune inflammatory process.\n4. **EEG Findings**: Focal slowing in the temporal regions is consistent with limbic involvement, as seen in anti-LGI1 encephalitis.\n5. **Exclusion of Other Options**:\n   - **Anti-NMDA receptor antibodies**: Typically presents with more prominent psychiatric symptoms, movement disorders, and normal or nonspecific MRI findings.\n   - **Anti-GABA-B receptor antibodies**: Often associated with seizures and paraneoplastic syndromes, which are not present here.\n   - **Anti-AMPA receptor antibodies**: Rare, usually paraneoplastic, and less likely in a young patient without malignancy.\n\nGiven the clinical, radiological, and laboratory findings, **anti-LGI1 antibodies** are the most likely cause of this patient's presentation."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "2_Diagnostic Evidence Team_Clinical Pathologist",
      "message": "**B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nThe clinical presentation of subacute **memory deficits, confusion, and behavioral changes**, along with **bilateral medial temporal lobe hyperintensities** on MRI, **mild lymphocytic pleocytosis** in the CSF, and **focal slowing in the temporal regions** on EEG, is highly characteristic of **limbic encephalitis**. Among the provided options, **anti-LGI1 antibodies** are the most strongly associated with this syndrome.\n\nKey considerations:\n1. **Anti-LGI1 antibodies** are the prototypical cause of autoimmune limbic encephalitis, particularly in middle-aged adults, and align perfectly with the clinical, radiological, and laboratory findings.\n2. **Anti-NMDA receptor antibodies** are less likely due to the absence of hallmark features such as psychiatric symptoms, dyskinesias, or autonomic instability, and the MRI findings are atypical for this condition.\n3. **Anti-GABA-B receptor antibodies** are less likely due to the absence of seizures and paraneoplastic features, which are more commonly seen with this condition.\n4. **Anti-AMPA receptor antibodies** are less likely due to the rarity of this condition in young adults without malignancy.\n\nThe consensus among all team members supports **anti-LGI1 antibodies** as the most likely diagnosis, making **B** the correct answer."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "3_Final Review and Decision Team_Psychiatrist",
      "message": "**Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating the analyses from all team members and reviewing the clinical presentation, diagnostic findings, and differential diagnoses, the most likely autoantibody associated with this case is **anti-LGI1 antibodies**. \n\n1. **Clinical Presentation**: The subacute onset of memory deficits, confusion, and behavioral changes over 3 weeks is characteristic of autoimmune limbic encephalitis.\n2. **Imaging Findings**: Bilateral medial temporal lobe hyperintensities on MRI are highly suggestive of limbic encephalitis, which is a hallmark of anti-LGI1 encephalitis.\n3. **CSF Analysis**: Mild lymphocytic pleocytosis supports an inflammatory or autoimmune process.\n4. **EEG Findings**: Focal slowing in the temporal regions aligns with dysfunction in the limbic system, further supporting the diagnosis of limbic encephalitis.\n5. **Differential Diagnosis**:\n   - **Anti-NMDA receptor antibodies**: Less likely due to the absence of hallmark psychiatric symptoms, movement disorders, or autonomic instability, as well as the presence of medial temporal lobe hyperintensities, which are atypical for this condition.\n   - **Anti-GABA-B receptor antibodies**: Less likely due to the absence of seizures and paraneoplastic features, which are commonly associated with this condition.\n   - **Anti-AMPA receptor antibodies**: Less likely due to the rarity in young patients and its frequent association with malignancies, which are not evident in this case.\n\n### Conclusion:\nThe clinical, radiological, and laboratory findings are most consistent with **anti-LGI1 antibody-associated limbic encephalitis**, making **B. Anti-LGI1 antibodies** the correct answer."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "3_Final Review and Decision Team_Neuropsychiatrist",
      "message": "**Final Answer: B. Anti-LGI1 antibodies**\n\n### Rationale:\nAfter integrating the analyses from all team members and considering the clinical presentation, imaging findings, CSF analysis, and EEG abnormalities, the diagnosis of **anti-LGI1 antibody-associated encephalitis** is the most likely.\n\n1. **Clinical Presentation**: Subacute onset of memory deficits, confusion, and behavioral changes is highly characteristic of limbic encephalitis, which is strongly associated with anti-LGI1 antibodies.\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are hallmark findings for anti-LGI1 encephalitis.\n3. **CSF Findings**: Mild lymphocytic pleocytosis aligns with the inflammatory process seen in autoimmune encephalitis.\n4. **EEG Findings**: Focal slowing in the temporal regions is consistent with limbic encephalitis and further supports the diagnosis.\n5. **Differential Diagnosis**:\n   - **Anti-NMDA receptor antibodies**: Less likely due to the absence of hallmark features like psychosis, dyskinesias, or autonomic instability, and the MRI findings are atypical.\n   - **Anti-GABA-B receptor antibodies**: Less likely due to the absence of seizures and paraneoplastic associations, which are common in this subtype.\n   - **Anti-AMPA receptor antibodies**: Less likely due to the rarity of this condition in younger individuals and the frequent association with malignancies, which is not present in this case.\n\nGiven the overwhelming alignment of the patient's presentation with the features of **anti-LGI1 encephalitis**, this is the most appropriate diagnosis."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "3_Final Review and Decision Team_Neurologist",
      "message": "**Correct Answer: B. Anti-LGI1 antibodies**\n\n### Final Rationale:\nAfter integrating the insights from all team members and my own analysis, the most likely diagnosis is **anti-LGI1 antibody-associated limbic encephalitis**. This conclusion is supported by the following:\n\n1. **Clinical Presentation**:\n   - Subacute onset of memory deficits, confusion, and behavioral changes is highly characteristic of autoimmune limbic encephalitis.\n   - Anti-LGI1 encephalitis is a classic cause of limbic encephalitis, particularly in middle-aged adults, and aligns perfectly with this patient's symptoms.\n\n2. **Imaging Findings**:\n   - MRI showing **bilateral medial temporal lobe hyperintensities** is a hallmark of anti-LGI1 encephalitis and strongly supports this diagnosis.\n\n3. **CSF and EEG Findings**:\n   - **Mild lymphocytic pleocytosis** in the CSF and **focal slowing in the temporal regions** on EEG are consistent with the inflammatory and focal nature of anti-LGI1 encephalitis.\n\n4. **Differentiation from Other Options**:\n   - **Anti-NMDA receptor antibodies**: Less likely due to the absence of hallmark psychiatric symptoms (e.g., psychosis, agitation) and the presence of characteristic MRI findings.\n   - **Anti-GABA-B receptor antibodies**: Less likely due to the absence of seizures and paraneoplastic features (e.g., small-cell lung cancer), which are commonly associated with this condition.\n   - **Anti-AMPA receptor antibodies**: Less likely due to the rarity in younger individuals and frequent association with malignancy, which is not evident in this case.\n\n### Conclusion:\nThe clinical, radiological, and laboratory findings are most consistent with **anti-LGI1 antibody-associated encephalitis**, making **B. Anti-LGI1 antibodies** the correct answer."
    }
  ],
  "decision_results": {
    "majority_voting": {
      "method": "majority_voting",
      "winning_option": "B",
      "vote_counts": {
        "B": 3
      },
      "total_votes": 3,
      "confidence": 1.0
    },
    "weighted_voting": {
      "method": "weighted_voting",
      "winning_option": null,
      "vote_counts": {},
      "weighted_votes": {},
      "total_votes": 0,
      "confidence": 0
    },
    "borda_count": {
      "method": "borda_count",
      "winning_option": "B",
      "borda_scores": {
        "A": 6,
        "B": 9,
        "C": 3,
        "D": 0
      },
      "total_possible_score": 18.0,
      "confidence": 0.5
    },
    "mdt_process": {
      "team_decisions": {
        "1_Initial Assessment Team": {
          "method": "majority_voting",
          "winning_option": "B",
          "vote_counts": {
            "B": 3
          },
          "total_votes": 3,
          "confidence": 1.0
        },
        "2_Diagnostic Evidence Team": {
          "method": "majority_voting",
          "winning_option": "B",
          "vote_counts": {
            "A": 1,
            "B": 2
          },
          "total_votes": 3,
          "confidence": 0.6666666666666666
        },
        "3_Final Review and Decision Team": {
          "method": "majority_voting",
          "winning_option": "B",
          "vote_counts": {
            "B": 3
          },
          "total_votes": 3,
          "confidence": 1.0
        }
      },
      "decision_team": "3_Final Review and Decision Team"
    }
  },
  "teamwork_metrics": {}
}